Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 300, Issue 1, 2002, Pages 245-256

  Ramakrishnan, Rohini ^a   Dubois, Debra C ^a   Almon, Richard R ^a   Pyszczynski, Nancy A ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOSOL RECEPTOR; MESSENGER RNA; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; TYROSINE AMINOTRANSFERASE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; BODY WEIGHT; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG INFUSION; ENZYME DEGRADATION; GENE AMPLIFICATION; INFUSION PUMP; LYMPHOCYTE COUNT; MALE; MINIPUMP; MODEL; NONHUMAN; ORGAN WEIGHT; PHARMACOGENOMICS; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; RNA TRANSLATION; SIGNAL TRANSDUCTION;

ADRENALECTOMY; ALGORITHMS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOWN-REGULATION; ENZYME INDUCTION; INFUSIONS, INTRAVENOUS; LYMPHOCYTES; MALE; METHYLPREDNISOLONE; ORGAN SIZE; RATS; RATS, WISTAR; RECEPTORS, STEROID;

EID: 0036139446     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.300.1.245     Document Type: Article

References (41)

1. Stress-induced changes of glucocorticoid receptor in rat liver
2. Tissue effects of glucocorticoids
3. Receptor-mediated pharmacodynamics of prednisolone in the rat
4. Effects of inhaled corticosteroids on the consequences of asthma
5. Anti-inflammatory therapy
6. Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone
7. Transcriptional and posttranscriptional regulation of tyrosine aminotransferase by insulin in rat hepatoma cells
8. Comparison of four basic models of indirect pharmacodynamic responses
9. Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences
10. Assay of tyrosine aminotransferase activity by conversion of p-hydroxyphenylpyruvate to p-hydroxybenzaldehyde
11. Molar quantification of specific messenger ribonucleic acid expression in northern hybridization using cRNA standards
12. Differential dynamics of receptor down-regulation and tyrosine aminotransferase induction following glucocorticoid treatment
13. Methylprednisolone disposition in rabbits. Analysis, prodrug conversion, reversible metabolism, and comparison with man
14. Multihormonal control of tyrosine aminotransferase in isolated liver cells
15. Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in rabbits
16. Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats
17. Pharmacoimmunodynamics of methylprednisolone: Trafficking of helper T lymphocytes
18. The cyclic adenosine 3',5'-monophosphate- and the glucocorticoid-dependent enhancers are targets for insulin repression of tyrosine aminotransferase gene transcription
19. Bioavailability and nonlinear disposition of methylprednisolone/methylprednisone in the rat
20. Transcriptional activation of the rat liver tyrosine aminotransferase gene by cAMP
21. Regulation of tyrosine alpha-ketoglutarate transaminase in rat liver. VI. Induction by pancreatic hormones
22. Depletion and replenishment of glucocorticoid receptor in cytosols of rat tissues after administration of various glucocorticoids
23. Tissue-specific regulation of glucocorticoid receptor mRNA by dexamethasone
24. Regulation of tyrosine alpha-ketoglutarate transaminase in rat liver. IX. Studies of the mechanisms of hormonal inductions in cultured hepatoma cells
25. Disposition of methylprednisolone and its sodium succinate prodrug in vivo and in perfused liver of rats: Nonlinear and sequential first-pass elimination
26. Protein measurement with the Folin phenol reagent
27. Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system
28. Regulation of tyrosine alpha-ketoglutarate transaminase in rat liver. 8. Inductions by hydrocortisone and insulin in cultured hepatoma cells
29. Stress down-regulates corticosterone receptors in a site-specific manner in the brain
30. Isolation of cDNA clones coding for rat tyrosine aminotransferase
31. Transcription activation of the tyrosine aminotransferase gene by glucocorticoids and cAMP in primary hepatocytes
32. Current management of inflammatory bowel disease
33. Insulin selectively slows the degradation rate of tyrosine aminotransferase
34. Fourth-generation model for corticosteroid pharmacodynamics: A model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine amino-transferase induction in rat liver
35. Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver
36. Corticosteroids: Clinical pharmacology and therapeutic use
37. Tyrosine-alpha-ketoglutarate transaminase: Induction by epinephrine and adenosine-3',5'-cyclic phosphate
38. Induction of phosphopyruvate carboxylase in neonatal rat liver by adenosine 3',5'-cyclic monophosphate
39. Receptor dynamics and tyrosine aminotransferase induction during the course of chronic treatment of rats with glucocorticoid